Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has announced results from a clinical study recently published in The Neurohospitalist highlighting the transformative impact of the Viz Connect care pathway on post-stroke patient care. The study demonstrates that the incorporation of Viz Connect drove improvements in cardiac monitoring utilization, care efficiency, healthcare provider (HCP) experience, and patient satisfaction. These data stem from a recent collaboration between Viz.ai and Medtronic to leverage AI-driven solutions to streamline communication between neurology and cardiology teams and accelerate critical interventions for stroke patients.
Timely follow-up with cardiac monitoring in post-stroke patient care is essential to identify atrial fibrillation (AFib), a leading cause of stroke, and to help prevent future AFib-related strokes. Viz Connect was designed to improve coordination between stroke specialists and electrophysiologists, enhancing post-stroke AFib assessment. To evaluate the impact of Viz Connect in addressing this gap, Brett Meyer, MD, lead author and professor of neurosciences at the University of California – San Diego (UCSD), spearheaded the single-center study comparing Viz Connect to existing processes. The study assessed Viz Connect’s ability to improve patient cardiac monitoring, reduce monitoring device placement times, and improve HCP and patient experience.
Dr. Meyer emphasized the platform’s impact: “Viz Connect has helped us improve how we coordinate care for stroke patients at risk of atrial fibrillation. By replacing a complex and fragmented system that relied on electronic medical record consults and direct physician-to-physician communication with Viz.ai’s streamlined platform, we achieved a robust increase in cardiac monitoring placements prior to discharge. The platform’s closed-loop communication, real-time alerts, and ease of use have not only improved clinician workflows but also enabled more meaningful patient discussions, paving the way for better risk reduction strategies and improved outcomes.”
Specific results include:
- Increased Access to Care: The number of patients receiving cardiac monitoring overall increased by 1.3x after adopting Viz Connect. Notably, the number of patients receiving guideline-driven cardiac monitoring specifically increased by 8.4x with Viz Connect, demonstrating its impact on advancing the standard of care.
- Improved Efficiency:
- Median time to device placement decreased by 97% (from 32 days to 1 day) for Insertable Cardiac Monitors (ICMs) and decreased by 59% (from 22 days to 9 days) for External Event Monitors (EMs).
- Improvements in median time to care were largely driven by Viz Connect’s ability to facilitate inpatient cardiac monitoring before discharge. Following Viz Connect implementation, the number of patients receiving appropriate ICM placement before discharge increased by 17x.
- Enhanced HCP and patient experience: 100% of surveyed clinicians preferred Viz Connect over the previous process and patient satisfaction scores improved once Viz Connect was implemented.
“This data shows a gap in guideline-based care that needs to be closed urgently to optimize secondary prevention of stroke. Our collaboration with Medtronic has produced concrete results that further validate how technology can improve care coordination,” said Prem Batchu-Green, Vice President of Care Pathways, Value & Success at Viz.ai. “By leveraging Viz.ai’s technology to streamline communication and accelerate intervention, we are empowering healthcare providers to achieve better outcomes for their patients.”
